TriVascular Investors

44 investors on Angel Roster list TriVascular in their portfolio. Most are venture capital firms and private equity firms, the most common stage is Series B and the largest groups are based in the United States and Puerto Rico.

Investors are matched on the company name in their portfolio, so companies that share the name TriVascular can appear together.

Investors listed
44
With verified email
48%
Most common stage
Series B
Top location
United States

Updated October 13, 2026 · How we compile this data

Top 40 TriVascular investors

The most complete profiles first. Showing 40 of 44.

  • Adam GreeneVerified

    Hedge Fund, Venture Capital, Investor · United States

    Series BHealth CareArtificial Intelligence (AI)Information ServicesInformation Technology (IT)

    Portfolio: RubiconMD, Four Points Innovation, AveXis, CathWorks and 76 more

    Verified email available

  • Narendra NayakVerified

    Hedge Fund, Venture Capital, Investor · United States

    Series BHealth CareArtificial Intelligence (AI)Information ServicesInformation Technology (IT)

    Portfolio: RubiconMD, Four Points Innovation, AveXis, CathWorks and 76 more

    Verified email available

  • Nicholas BishopVerified

    Hedge Fund, Venture Capital, Investment Partner · United States

    Series BHealth CareInvestment ManagementArtificial Intelligence (AI)Information Services

    Portfolio: RubiconMD, Four Points Innovation, AveXis, CathWorks and 76 more

    Verified email available

  • Adam WhiteheadVerified

    Private Equity Firm · United States

    Health CareHospitalsWomen FoundedBiotechnology

    Portfolio: HNI Healthcare, Navidea Biopharmaceuticals, Astute Medical, T2 Biosystems and 37 more

    Verified email available

  • Ben WessnerVerified

    Venture Capital, Private Equity Firm · United States

    Health CareHospitalsWomen FoundedBiotechnology

    Portfolio: HNI Healthcare, Navidea Biopharmaceuticals, Astute Medical, T2 Biosystems and 37 more

    Verified email available

  • Brian EnglanderVerified

    Venture Capital, Private Equity Firm · United States

    Health CareHospitalsWomen FoundedBiotechnology

    Portfolio: HNI Healthcare, Navidea Biopharmaceuticals, Astute Medical, T2 Biosystems and 37 more

    Verified email available

  • Brian GoodmanVerified

    Venture Capital, Private Equity Firm, Investment Partner · United States

    Health CareGeneticsLife ScienceInformation Technology (IT)

    Portfolio: CoStim Pharmaceuticals, InformedDNA, Mitobridge, Verastem Oncology and 56 more

    Verified email available

  • Chris GrantVerified

    Corporate Venture Capital · United States

    Health CareHospitalsGeneticsWellness

    Portfolio: iRhythm Technologies, Arcxis Biotechnologies, Kit Check, IntelyCare and 52 more

    Verified email available

  • Dylan HarmonVerified

    Private Equity Firm · United States

    Health CareHospitalsWomen FoundedBiotechnology

    Portfolio: HNI Healthcare, Navidea Biopharmaceuticals, Astute Medical, T2 Biosystems and 37 more

    Verified email available

  • Howie FurstVerified

    Hedge Fund, Investment Partner · United States

    Health CareArtificial Intelligence (AI)Information ServicesInformation Technology (IT)

    Portfolio: RubiconMD, Four Points Innovation, AveXis, CathWorks and 76 more

    Verified email available

  • Julia MooreVerified

    Venture Capital, Private Equity Firm, Angel/Individual · United States

    Health CareDisruptive ModelsAndroidEnergy

    Portfolio: Cambrian Genomics, Immusoft, TriVascular, Cortexyme and 7 more

    Verified email available

  • Kevin BergVerified

    Hedge Fund, Investment Partner · United States

    Health CareArtificial Intelligence (AI)Information ServicesInformation Technology (IT)

    Portfolio: RubiconMD, Four Points Innovation, AveXis, CathWorks and 76 more

    Contact details available

  • Luke EvninVerified

    Venture Capital, Private Equity Firm · United States

    Health CareGeneticsLife ScienceInformation Technology (IT)

    Portfolio: CoStim Pharmaceuticals, InformedDNA, Mitobridge, Verastem Oncology and 56 more

    Verified email available

  • Matthew PotterVerified

    Venture Capital, Investor · United States

    Health CareData IntegrationWearablesAutonomous Vehicles

    Portfolio: BARRX Medical, Lutonix, Karyopharm Therapeutics, Vital Therapies and 48 more

    Verified email available

  • Scott LiVerified

    Venture Capital, Private Equity Firm · United States

    Health CareHospitalsWomen FoundedBiotechnology

    Portfolio: HNI Healthcare, Navidea Biopharmaceuticals, Astute Medical, T2 Biosystems and 37 more

    Verified email available

  • Shinichiro FuseVerified

    Venture Capital, Private Equity Firm · United States

    Health CareGeneticsLife ScienceInformation Technology (IT)

    Portfolio: CoStim Pharmaceuticals, InformedDNA, Mitobridge, Verastem Oncology and 56 more

    Verified email available

  • Todd FoleyVerified

    Venture Capital, Private Equity Firm, Investment Partner · United States

    Health CareGeneticsLife ScienceInformation Technology (IT)

    Portfolio: CoStim Pharmaceuticals, InformedDNA, Mitobridge, Verastem Oncology and 56 more

    Verified email available

  • Todd HolmesVerified

    Private Equity Firm · United States

    Health CareHospitalsWomen FoundedBiotechnology

    Portfolio: HNI Healthcare, Navidea Biopharmaceuticals, Astute Medical, T2 Biosystems and 37 more

    Verified email available

  • Vincent MelletVerified

    Hedge Fund, Investment Partner · United States

    Health CareArtificial Intelligence (AI)Information ServicesInformation Technology (IT)

    Portfolio: RubiconMD, Four Points Innovation, AveXis, CathWorks and 76 more

    Verified email available

  • Andrew JensenVerified

    Venture Capital · United States

    Health CareManufacturingBiotechnologyClinical Trials

    Portfolio: Cybin, TriVascular, Boreal Genomics, NextWave Pharmaceuticals and 5 more

    Verified email available

  • Caley CasteleinVerified

    Venture Capital · United States

    Health CareManufacturingBiotechnologyClinical Trials

    Portfolio: Cybin, TriVascular, Boreal Genomics, NextWave Pharmaceuticals and 5 more

    Verified email available

  • Daniel van den Bergh

    Venture Capital, Corporate Venture Capital · United States

    Series BHealth CareHospitalsGeneticsWellness

    Portfolio: iRhythm Technologies, Arcxis Biotechnologies, Kit Check, IntelyCare and 60 more

    Contact details available

  • Ed Hurwitz

    Venture Capital, Private Equity Firm, Investor · United States

    SeedHealth CareGeneticsLife ScienceInformation Technology (IT)

    Portfolio: CoStim Pharmaceuticals, Protego Biopharma, InformedDNA, Mitobridge and 60 more

    Contact details available

  • James Flynn

    Hedge Fund, Venture Capital, Investor · United States

    Series BHealth CareInvestment ManagementArtificial Intelligence (AI)Information Services

    Portfolio: RubiconMD, Four Points Innovation, AveXis, CathWorks and 80 more

    Contact details available

  • Stephen Curtis

    Venture Capital, Private Equity Firm, Investor · United States

    SeedHealth CareGeneticsLife ScienceInformation Technology (IT)

    Portfolio: CoStim Pharmaceuticals, InformedDNA, Mitobridge, Verastem Oncology and 56 more

    Contact details available

  • Amy Raimundo

    Corporate Venture Capital · United States

    Health CareHospitalsGeneticsWellness

    Portfolio: iRhythm Technologies, Arcxis Biotechnologies, Kit Check, IntelyCare and 52 more

    Contact details available

  • Arun Ramamoorthy

    Venture Capital · United States

    AdvertisingTelecommunicationsE-commercePayments

    Portfolio: Ze-gen, Quidsi, Spiracur, Videology and 48 more

    Contact details available

  • Avi Kometz

    Hedge Fund, Investment Partner · United States

    Health CareArtificial Intelligence (AI)Information ServicesInformation Technology (IT)

    Portfolio: RubiconMD, Four Points Innovation, AveXis, CathWorks and 76 more

    Contact details available

  • Christiana Bardon M.D.

    Venture Capital, Private Equity Firm, Investment Partner · United States

    Health CareGeneticsInvestment ManagementLife Science

    Portfolio: CoStim Pharmaceuticals, InformedDNA, Mitobridge, Verastem Oncology and 56 more

    Contact details available

  • Deepa Pakianathan Ph.D.

    Venture Capital, Private Equity Firm · United States

    Health CareData IntegrationWearablesAutonomous Vehicles

    Portfolio: BARRX Medical, Lutonix, Karyopharm Therapeutics, Vital Therapies and 48 more

    Contact details available

  • Doug Roeder

    Venture Capital · United States

    Health CareData IntegrationWearablesAutonomous Vehicles

    Portfolio: BARRX Medical, Lutonix, Karyopharm Therapeutics, Vital Therapies and 48 more

    Contact details available

  • Justin Waney

    Private Equity Firm · United States

    Health CareHospitalsWomen FoundedBiotechnology

    Portfolio: HNI Healthcare, Navidea Biopharmaceuticals, Astute Medical, T2 Biosystems and 37 more

    Contact details available

  • Leigh Zawel

    Venture Capital, Private Equity Firm · United States

    Health CareGeneticsLife ScienceInformation Technology (IT)

    Portfolio: CoStim Pharmaceuticals, InformedDNA, Mitobridge, Verastem Oncology and 56 more

    Contact details available

  • Liz Rockett

    Venture Capital, Corporate Venture Capital · United States

    Health CareHospitalsGeneticsWellness

    Portfolio: iRhythm Technologies, Arcxis Biotechnologies, Kit Check, IntelyCare and 52 more

    Contact details available

  • Luke Duster

    Venture Capital, Private Equity Firm · United States

    Health CareHospitalsWomen FoundedInvestment Management

    Portfolio: HNI Healthcare, Navidea Biopharmaceuticals, Astute Medical, T2 Biosystems and 37 more

    Contact details available

  • Nate Hukill

    Venture Capital, Private Equity Firm · Puerto Rico

    Health CareHospitalsWomen FoundedInvestment Management

    Portfolio: HNI Healthcare, Navidea Biopharmaceuticals, Astute Medical, T2 Biosystems and 37 more

    Contact details available

  • Nemariam Mesfin

    Corporate Venture Capital · United States

    Health CareHospitalsGeneticsWellness

    Portfolio: iRhythm Technologies, Arcxis Biotechnologies, Kit Check, IntelyCare and 52 more

    Contact details available

  • Olivia Capra

    Corporate Venture Capital · United States

    Health CareHospitalsGeneticsWellness

    Portfolio: iRhythm Technologies, Arcxis Biotechnologies, Kit Check, IntelyCare and 52 more

    Contact details available

  • Sam Brasch

    Corporate Venture Capital · United States

    Health CareHospitalsGeneticsWellness

    Portfolio: iRhythm Technologies, Arcxis Biotechnologies, Kit Check, IntelyCare and 52 more

    Contact details available

  • Sami Hawwa

    Private Equity Firm · United States

    Health CareHospitalsWomen FoundedBiotechnology

    Portfolio: HNI Healthcare, Navidea Biopharmaceuticals, Astute Medical, T2 Biosystems and 37 more

    Contact details available

See all 44 TriVascular investors

Search, filter and unlock verified emails and LinkedIn profiles. Free to browse.

Frequently asked questions

How many TriVascular investors are on Angel Roster?

Angel Roster lists 44 TriVascular investors. 21 of them (48%) include a verified email address.

What types of investors are they?

The most common investor types are Venture Capital Firms (29), Private Equity Firms (22) and Investment Partner Investors (8). An investor can have more than one type, for example an angel who is also a venture partner.

Which stages do TriVascular investors invest in?

Among those that list a stage, the most common are Series B (6) and Seed (2).

Where are TriVascular investors based?

Most are based in the United States (43) and Puerto Rico (1).

Which companies have TriVascular investors backed?

The most-backed portfolio companies among them are Astute Medical (30), Valeritas (27), Nevro (20), Proteon Therapeutics (17) and Oncorus (17).

How do I contact TriVascular investors?

Create a free Angel Roster account to search and filter all 44, then unlock verified emails and LinkedIn profiles on a paid plan. Every plan starts with a 3-day free trial.